These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 1461948

  • 41. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
    Zis AP, Haskett RF, Albala AA, Carroll BJ, Lohr NE.
    Arch Gen Psychiatry; 1985 Apr; 42(4):383-6. PubMed ID: 3977556
    [Abstract] [Full Text] [Related]

  • 42. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [Abstract] [Full Text] [Related]

  • 43. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
    Schweitzer I, Tuckwell VM, Maguire KP, Tiller JW, Harrison LC, Davies BM.
    Psychoneuroendocrinology; 1991 Mar; 16(5):375-82. PubMed ID: 1805291
    [Abstract] [Full Text] [Related]

  • 44. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.
    Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Blüher M, Kratzsch J, Then Bergh F.
    Psychoneuroendocrinology; 2017 Apr; 78():39-47. PubMed ID: 28167369
    [Abstract] [Full Text] [Related]

  • 45. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H.
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [Abstract] [Full Text] [Related]

  • 46. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol.
    Halbreich U, Naor S, Asnis G, Gasparini F, Goldstein S, Vital-Herne J, Kang BJ.
    Biol Psychiatry; 1986 Dec; 21(14):1434-7. PubMed ID: 3790627
    [No Abstract] [Full Text] [Related]

  • 47. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.
    Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL.
    Arch Gen Psychiatry; 1987 Apr; 44(4):328-36. PubMed ID: 3566455
    [Abstract] [Full Text] [Related]

  • 48. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
    Kathol RG, Jaeckle RS, Lopez JF, Meller WH.
    Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
    [Abstract] [Full Text] [Related]

  • 49. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L, Boucher H.
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract] [Full Text] [Related]

  • 50. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder.
    Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH.
    Br J Psychiatry; 2004 Jun; 184():496-502. PubMed ID: 15172943
    [Abstract] [Full Text] [Related]

  • 51. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania.
    Swann AC, Stokes PE, Casper R, Secunda SK, Bowden CL, Berman N, Katz MM, Robins E.
    Acta Psychiatr Scand; 1992 Apr; 85(4):270-4. PubMed ID: 1595360
    [Abstract] [Full Text] [Related]

  • 52. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW, Quitkin FM, McGrath PJ, Klein DF.
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [Abstract] [Full Text] [Related]

  • 53. The hypothalamic-pituitary-thyroid axis in depressive patients and healthy subjects in relation to the hypothalamic-pituitary-adrenal axis.
    Kjellman BF, Thorell LH, Orhagen T, d'Elia G, Kågedal B.
    Psychiatry Res; 1993 Apr; 47(1):7-21. PubMed ID: 8516419
    [Abstract] [Full Text] [Related]

  • 54. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T, Python A, Schulz PE, Aubry JM.
    Psychoneuroendocrinology; 2007 Jun; 32(5):575-9. PubMed ID: 17512120
    [Abstract] [Full Text] [Related]

  • 55. Adrenocorticotropin and cortisol response to lysine vasopressin in relation to the outcome of the dexamethasone suppression test in major depressive disorder.
    Akner G, Ljunggren JG, Kjellman BF, Undén F, Wetterberg L.
    Acta Psychiatr Scand; 1988 Apr; 77(4):404-10. PubMed ID: 2839010
    [Abstract] [Full Text] [Related]

  • 56. Hypothalamic-pituitary-adrenal axis activity and tricyclic response in major depression.
    Nelson WH, Orr WW, Stevenson JM, Shane SR.
    Arch Gen Psychiatry; 1982 Sep; 39(9):1033-6. PubMed ID: 7115012
    [Abstract] [Full Text] [Related]

  • 57. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF, Prudic J, Rothpearl A, Nurnberg HG.
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [Abstract] [Full Text] [Related]

  • 58. Dexamethasone suppression testing in chronic renal failure: pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis.
    Workman RJ, Vaughn WK, Stone WJ.
    J Clin Endocrinol Metab; 1986 Sep; 63(3):741-6. PubMed ID: 3734041
    [Abstract] [Full Text] [Related]

  • 59. DST in depression is unaffected by altering the clock time of its administration.
    Pepper GM, Davis KL, Davis BM, Krieger DT.
    Psychiatry Res; 1983 Feb; 8(2):105-9. PubMed ID: 6574528
    [Abstract] [Full Text] [Related]

  • 60. Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers.
    Amsterdam JD, Maislin G, Winokur A, Kling M, Gold P.
    Arch Gen Psychiatry; 1987 Sep; 44(9):775-81. PubMed ID: 2820340
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.